Peroxisome proliferator-activated receptor gamma induces pancreatic cancer cell apoptosis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11554760
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 15-deoxy-Delta(12,14)PGJ(2) induces diverse biological responses via PPARgamma activation in cancer cells.

  2000cited by this paper
• Apoptosis induction and cyclooxygenase‐2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase‐2‐selective non‐steroidal anti‐inflammatory drug NS‐398

  2000cited by this paper
• Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.

  2000cited by this paper
• PPARgamma ligand (thiazolidinedione) induces growth arrest and differentiation markers of human pancreatic cancer cells.

  2000cited by this paper
• Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.

  2000cited by this paper
• Expression of peroxisome proliferator-activated receptors (PPARS) in human astrocytic cells: PPARgamma agonists as inducers of apoptosis.

  2000cited by this paper
• PPARgamma inhibits the expression of c-MET in human gastric cancer cells through the suppression of Ets.

  1999cited by this paper
• 15-Deoxy-Delta(12,14)-prostaglandin J(2), a ligand for peroxisome proliferator-activated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells.

  1999cited by this paper
• Influence of J series prostaglandins on apoptosis and tumorigenesis of breast cancer cells.

  1999cited by this paper
• Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma.

  1999cited by this paper
• Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.

  1999cited by this paper
• Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2 *

  1999cited by this paper
• Peroxisome proliferator-activated receptor gamma activation in human breast cancer.

  1999cited by this paper
• Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

  1998cited by this paper
• Activators of the nuclear receptor PPARgamma enhance colon polyp formation.

  1998cited by this paper
• Mechanism of action of fibrates on lipid and lipoprotein metabolism.

  1998cited by this paper
• PPARgamma in monocytes: less pain, any gain?

  1998cited by this paper
• Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

  1998cited by this paper
• Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

  1998cited by this paper
• The nuclear receptor PPARgamma - bigger than fat.

  1998cited by this paper
• Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

  1997cited by this paper
• Adipogenesis and obesity: rounding out the big picture.

  1996cited by this paper
• 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

  1995cited by this paper
• Novel Sequence Determinants in Peroxisome Proliferator Signaling (*)

  1995cited by this paper
• A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.

  1995cited by this paper
• Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

  1992cited by this paper
• Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

  1990cited by this paper
• Biochemical mechanisms of induction of hepatic peroxisome proliferation.

  1989cited by this paper
• Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens

  1980cited by this paper

• Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways

  2024cites this paper
• Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer

  2022cites this paper
• Utilizing systems biology to reveal cellular responses to peroxisome proliferator-activated receptor γ ligand exposure

  2021cites this paper
• Preliminary evaluation of anticancer efficacy of pioglitazone combined with celecoxib for the treatment of non-small cell lung cancer

  2021cites this paper
• The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics.

  2021cites this paper
• How cancer cells remodel lipid metabolism: strategies targeting transcription factors

  2021cites this paper
• Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients

  2021cites this paper
• CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer

  2020cites this paper
• The role of the lipidome in obesity-mediated colon cancer risk.

  2018cites this paper
• Phthalate exposure, flavonoid consumption and breast cancer risk among Mexican women.

  2016cites this paper
• jmbReview Peroxisome Proliferator-Activated Receptor-Gamma Agonist 4O-Methylhonokiol Induces Apoptosis by Triggering the Intrinsic Apoptosis Pathway and Inhibiting the PI 3 K / Akt Survival Pathway in SiHa Human Cervical Cancer Cells

  2015cites this paper
• Prognostic significance and therapeutic implications of peroxisome proliferator-activated receptor γ overexpression in human pancreatic carcinoma.

  2015cites this paper
• Peroxisome proliferator-activated receptor-gamma agonist 4-O-methylhonokiol induces apoptosis by triggering the intrinsic apoptosis pathway and inhibiting the PI3K/Akt survival pathway in SiHa human cervical cancer cells.

  2015cites this paper
• Diabetes Mellitus as a Novel Risk Factor for Gastrointestinal Malignancies

  2014cites this paper
• The aryl hydrocarbon receptor nuclear translocator (ARNT) modulates the antioxidant response in AML cells.

  2013cites this paper
• Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.

  2013cites this paper
• A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4.

  2012cites this paper
• Identification and functional activation of peroxisome proliferator-activated receptor in human upper aerodigestive cancer

  2012influential citation
• PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells.

  2011cites this paper
• The complexities of obesity and diabetes with the development and progression of pancreatic cancer.

  2011cites this paper
• The complexities of obesity , diabetes , and the development and progression of pancreatic cancer

  2011cites this paper
• Enhanced PPAR-gamma expression may correlate with the development of Barrett's esophagus and esophageal adenocarcinoma.

  2011cites this paper
• Combined treatment with the Cox-2 inhibitor niflumic acid and PPARγ ligand ciglitazone induces ER stress/caspase-8-mediated apoptosis in human lung cancer cells.

  2011cites this paper
• Therapeutic Implications of PPARγ in Human Osteosarcoma

  2010cites this paper
• PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.

  2010cites this paper
• PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study

  2010cites this paper
• The PPARγ Agonist Rosiglitazone Inhibits Glioma Cell Proliferation and Migration in vitro and Glioma Tumor Growth in vivo

  2009cites this paper
• Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma.

  2009cites this paper
• The Role of PPARγ Receptors and Leukotriene B4 Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer

  2009cites this paper
• Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells.

  2009cites this paper
• Pioglitazone, a PPAR-gamma ligand, exerts cytostatic/cytotoxic effects against cancer cells, that do not result from inhibition of proteasome.

  2008cites this paper
• Gamma tocotrienol and prostate cancer: The regulation of two independent pathways to potentiate cell growth inhibition and apoptosis

  2008cites this paper
• Opposing Effects of n-6 and n-3 Polyunsaturated Fatty Acids on Pancreatic Cancer Growth

  2008cites this paper
• Ciglitazone induces caspase-independent apoptosis via p38-dependent AIF nuclear translocation in renal epithelial cells.

  2008cites this paper
• PPARγ and Apoptosis in Cancer

  2008cites this paper
• Primers on Molecular Pathways: Nuclear Receptors in Pancreatic Cancer

  2008cites this paper
• Peroxisome proliferator-activated receptor-γ activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis

  2008cites this paper
• A Phase I Study of Bexarotene and Rosiglitazone in Patients with Refractory Cancers

  2008cites this paper
• Modulation of cell growth and PPARgamma expression in human colorectal cancer cell lines by ciglitazone.

  2008cites this paper
• The Role of PPAR-γ and Its Interaction with COX-2 in Pancreatic Cancer

  2008cites this paper
• The Role of PPARs in Cancer

  2008cites this paper
• Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.

  2007cites this paper
• New mechanism-based anticancer drugs that act as orphan nuclear receptor agonists

  2007cites this paper
• Leukemia stem cells in a genetically defined murine model of blast-crisis CML.

  2007cites this paper
• Peroxisome proliferator-activated receptor gamma agonists inhibit the proliferation and invasion of human colon cancer cells.

  2007cites this paper
• 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.

  2007cites this paper
• Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone.

  2007cites this paper
• Biology of PPAR gamma in cancer: a critical review on existing lacunae.

  2007cites this paper
• Nutrigenomics: concepts and applications to pharmacogenomics and clinical medicine.

  2007cites this paper
• Inhibition of peroxisome proliferator‐activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties

  2006cites this paper
• Differential modulation of cell cycle, apoptosis and PPARgamma2 gene expression by PPARgamma agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells.

  2006cites this paper
• Activation of Peroxisome Proliferator-Activated Receptor-γ Decreases Pancreatic Cancer Cell Invasion through Modulation of the Plasminogen Activator System

  2006cites this paper
• Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1

  2006cites this paper
• Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.

  2006cites this paper
• A Ligand for Peroxisome Proliferator-Activated Receptor γ Inhibits Human Cholangiocarcinoma Cell Growth: Potential Molecular Targeting Strategy for Cholangioma

  2006cites this paper
• Differential expression of peroxisome proliferator-activated receptor in histologically different human gastric cancer tissues.

  2006cites this paper
• Peroxisome proliferator-activated receptor gamma in malignant diseases.

  2006cites this paper
• Peroxisome Proliferator-Activated Receptor γ Is Highly Expressed in Pancreatic Cancer and Is Associated With Shorter Overall Survival Times

  2006cites this paper
• Effects of PPARgamma agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line.

  2006cites this paper
• Troglitazone Inhibits Cell Growth and Induces Apoptosis of B-Cell Acute Lymphoblastic Leukemia Cells with t(14;18)

  2006cites this paper
• [Decreased PPARs activity mediated induction of anoikis and inability of cell adhesion and invasion in colorectal carcinoma cells].

  2006cites this paper
• Peroxisome Proliferator-Activated Receptor γ and Growth Inhibition by Its Ligands in Uterine Endometrial Carcinoma

  2006cites this paper
• Fatty acid-activated nuclear transcription factors and their roles in human placenta

  2006cites this paper
• Effects of PPARγ agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line

  2006cites this paper
• New indications for established drugs: combined tumor-stroma-targeted cancer therapy with PPARgamma agonists, COX-2 inhibitors, mTOR antagonists and metronomic chemotherapy.

  2005cites this paper
• The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.

  2005cites this paper
• Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro.

  2005cites this paper
• Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells.

  2005cites this paper
• The CNS pericyte response to low oxygen: early synthesis of cyclopentenone prostaglandins of the J-series.

  2005cites this paper
• Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.

  2005cites this paper
• Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma.

  2005cites this paper
• In vitro age-related responses of endothelial cells to breast cancer cell addition.

  2005cites this paper
• Expression and activation of peroxisome proliferator‐activated receptors in growth plate chondrocytes

  2005cites this paper
• Critical Role of Peroxisome Proliferator-Activated Receptor γ on Anoikis and Invasion of Squamous Cell Carcinoma

  2005cites this paper
• The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.

  2005cites this paper
• Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.

  2005cites this paper
• Prostaglandin J2 family and the cardiovascular system.

  2004cites this paper
• Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis.

  2004cites this paper
• On the role of the islets of Langerhans in pancreatic cancer.

  2004cites this paper
• Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ Is Modulated by SUMO-1 Modification*

  2004cites this paper
• Transcriptional Regulation of Murine Slc 22 a 11 ( Oct 1 ) by Peroxisome-proliferator agonist receptor ( PPAR )-alpha and-gamma

  2004cites this paper
• Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.

  2004cites this paper
• Possible involvement of p38 in mechanisms underlying acceleration of proliferation by 15-deoxy-Delta(12,14)-prostaglandin J2 and the precursors in leukemia cell line THP-1.

  2004cites this paper
• Induction of Proliferation by 15-Deoxy-Δ12,14-Prostaglandin J2 and the Precursors in Monocytic Leukemia U937

  2004cites this paper
• Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells

  2004cites this paper
• Dose-dependent transitions in mechanisms of toxicity: case studies.

  2004cites this paper
• COX and PPAR: Possible Interactions in Pancreatic Cancer

  2004cites this paper
• Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.

  2004cites this paper
• Cell Death Pathways in Pancreatitis and Pancreatic Cancer

  2004cites this paper
• Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells.

  2003cites this paper
• Expression of NPM-RARα fusion gene in hematopoietic cells confers sensitivity to troglitazone-induced apoptosis

  2003cites this paper
• Peroxisome Proliferator-Activated Receptor-γ Activator 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits Neuroblastoma Cell Growth through Induction of Apoptosis: Association with Extracellular Signal-Regulated Kinase Signal Pathway

  2003cites this paper
• Apoptosis in Human Oral Squamous Cell Carcinomas is Induced by 15-Deoxy-Δ12,14-Prostaglandin J2 but not by Troglitazone

  2003cites this paper
• Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.

  2003cites this paper
• Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.

  2003cites this paper
• Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis.

  2003cites this paper
• Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.

  2003cites this paper
• Expression of PPAR-gamma is correlated with the clinical course of neuroblastoma.

  2003cites this paper
• PPARalpha agonist-induced rodent tumors: modes of action and human relevance.

  2003cites this paper
• 15‐hydroxy‐eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator‐activated receptor gamma‐dependent pathway

  2003cites this paper